AMPE

Ampio Pharmaceuticals Stock Price

1.405
-0.045 (-3.1%)
Upgrade to Real-Time
Regular Market
1.405

Low
0.6209

52 Week Range

High
2.98

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.045 -3.1% 1.405 13:44:26
Open Price Low Price High Price Close Price Prev Close
1.42 1.38 1.46 1.45
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,166 686,702 $ 1.42 $ 972,638 - 0.6209 - 2.98
Last Trade Time Type Quantity Stock Price Currency
13:45:49 54 $ 1.4001 USD

Period:

Draw Mode:

Ampio Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 276.57M 196.85M 194.23M $ - $ - -0.10 -18.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -164.73k 1.50%

more financials information »

Ampio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMPE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.481.601.381.50878,737-0.075-5.07%
1 Month1.761.791.351.591,184,413-0.355-20.17%
3 Months1.852.001.351.761,952,708-0.445-24.05%
6 Months1.742.591.251.852,405,481-0.335-19.25%
1 Year1.122.980.62091.563,557,3310.28525.45%
3 Years3.003.200.261.132,156,775-1.60-53.17%
5 Years0.97994.94990.261.261,576,8140.425143.38%

Ampio Pharmaceuticals Description

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.


Your Recent History
AMEX
AMPE
Ampio Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.